logo-loader
CNSX:PILL

Canntab Therapeutics Ltd

Receive alerts
Market:
CNSX
Market Cap:
$15.18 m
Price
$0.60
Change
-3.23%
52 weeks high
2.14
52 weeks low
0.40

Filter by article type

Viewing results 1-25 of 55

Health

Buds & Duds: Cannabis stocks recover on Friday; Canntab shares soar on positive finding of patentability

Also on the move were Canntab Therapeutics Limited, The Green Organic Dutchman Holdings, HEXO, Tilray and High Tide...

on 08/16/2019
Health

Canntab's plans boosted by initial indication of patentability for its immediate release CBD formulation

Canntab has successfully created a line of patent-pending precision oral delivery hard tablets...

on 08/15/2019
Health

Cannabis pill developer Canntab Therapeutics making solid progress in bringing its products to market

Canntab's oral delivery system treats different ailments by delivering a uniform dosage of medicinal cannabis extract...

on 07/31/2019
Health

Canntab Therapeutics making final steps towards bringing its products to market

The group said it would start manufacturing commercial batches of oil-filled gel capsules at its facility in Ontario and request Health Canada approval to begin full scale production and sale...

on 07/31/2019
Health

Buds & Duds: Cannabis stocks plummet, but Canntab bucks the trend as shares rise

Also on the move were Cannabis One, Golden Leaf, Isodiol, MedMen, Tilray and Green Growth Brands...

on 05/31/2019
Health

Canntab Therapeutics inks pact with Heritage Cannabis for processing hemp for CBD-filled gelcaps

Heritage's subsidiary Purefarma Solutions will take hemp from Canntab for the purpose of processing it into high-quality CBD oil...

on 05/30/2019
Health

Buds & Duds: Cannabis stocks climb; Canntab shares soar on hemp-cultivation licence

Also on the move were PreveCeutical, The Supreme Cannabis Company, Cronos, Golden Leaf Holdings and Isodiol International...

on 05/21/2019
Health

Canntab Therapeutics hits new milestone with hemp-processing licence from Health Canada

Canntab intends to use the licence to secure large amounts of hemp biomass that it will use to extract cannabidiol (CBD) to manufacture cannabis pills...

on 05/21/2019
Health

Heritage Cannabis to start trading on the OTCQX best market

CEO Clint Sharples said the move will give US investors easier access to investing in shares of Heritage...

on 05/17/2019
Health

Buds & Duds: Cannabis stocks flatten out; Canntab shares pop on OTCQX listing news

Also on the move were Curaleaf, The Green Organic Dutchman Holdings, Sunniva, CannTrust and TILT...

on 05/01/2019
Health

Canntab Therapeutics to start trading on OTCQX best market

CEO Jeff Renwick says the move aligns with the company’s goal to be a ‘global leader’ of research and production in hard pill oral dosage therapeutic cannabis...

on 05/01/2019
Health

Canntab Therapeutics edges closer to revenue generation after FSD Pharma granted sales license

FSD’s new sales license allows Canntab to produce samples of CBD-containing capsules, which will enable the company to begin production and sales from its manufacturing space in FSD’s Cobourg facility...

on 04/23/2019
Health

Canntab Therapeutics inks organic hemp supply and loan deal with FSD Pharma and World Class Extractions

The trio of companies will buy up to C$5 million of Thomas Elcome’s hemp crop for five years starting in 2019 ...

on 02/28/2019
Health

FSD Pharma and Canntab Therapeutics forge pact with World Class Extractions to strike hemp deal

The three companies will buy about 1,000 kg of Thomas Elcome’s 2018 hemp crop...

on 02/12/2019
Health

Canntab Therapeutics teams up with orthopedic surgeon for cannabis tablet trial

A placebo-controlled study led by Dr Don Garbuz will test the effectiveness of the company’s Canntab product in reducing the need for opioids after knee-replacement surgery...

on 12/05/2018